Free Flow Medical is developing the FreeFlow® Coil System, a bronchoscopic lung volume reduction treatment specifically designed for patients with severe emphysema. This device enhances lung function and exercise capacity, significantly improving the quality of life for individuals suffering from chronic obstructive pulmonary disease (COPD).
Funding
$11.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Severe emphysema leads to reduced lung function, diminished exercise capacity, and a significantly impaired quality of life for patients with chronic obstructive pulmonary disease (COPD). Current treatments may not be suitable for all patients, and there is a need for less invasive interventions that can improve lung function regardless of collateral ventilation.
Solution
Free Flow Medical provides the FreeFlow® Coil System, a bronchoscopic lung volume reduction (BLVR) treatment designed to improve lung function in patients with severe emphysema. The FreeFlow® Coil System is deployed via bronchoscopy and is independent of the presence of collateral ventilation. This minimally invasive approach aims to enhance lung function, increase exercise capacity, and improve the overall quality of life for individuals suffering from COPD.
Target Audience
The primary audience includes healthcare professionals, specifically pulmonologists and bronchoscopists, who treat patients with severe emphysema, as well as patients seeking minimally invasive options to improve their lung function and quality of life.
Features
- Bronchoscopic Lung Volume Reduction (BLVR) using shape-memory alloy coils
- Minimally invasive procedure performed via bronchoscopy
- Designed for patients with severe emphysema
- Improves lung function, exercise capacity, and quality of life
- Independent of collateral ventilation
- Available in two sizes: FreeFlow® Coil #2 System and FreeFlow® Coil #4 System